Objectives

• To lead the sex/gender medicine approach to metabolic diseases of high prevalence in Spain.
• To lead transfer research in reproductive endocrinology and intermediary metabolism.
• To lead the transfer of scientific knowledge to clinical practice in reproductive endocrinology.

Research lines

• Evolution of female androgen excess associated with obesity after weight loss.
• Evolution of male hypogonadism associated with obesity after weight loss.
• Influence of obesity and gonadal dysfunction on early cardiovascular disease markers and cardiovascular risk markers.
• Obesity as a cardiovascular risk factor in women and men.
• Influence of treatment of gonadal dysfunction in both sexes (polycystic ovary syndrome or functional hypogonadotropic hypogonadism) on visceral adiposity and metabolic dysfunction.
• Sexual dimorphism of cardioautonomic neuropathy in subjects with type 1 diabetes mellitus.